← Leaderboards
Dimitrios P Kontoyiannis
University Of Tx Md Anderson Can Ctr
$2,300,754
Attributed
$3,516,712
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $753K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,516,712 · 8
By mechanism
R33$1,419,007 · 1
R21$868,735 · 2
P01$752,970 · 2
R03$476,000 · 3
Top collaborators
- Pappanaicken Rangasamy Kumaresan6 shared
- Wadih Arap2 shared
- Renata Pasqualini2 shared
Others in their field
Top investigators on “Aspergillosis”
- Robert Andrew Cramer · Sloan-Kettering Inst Can Research$13,470,091
- Tobias M Hohl · Sloan-Kettering Inst Can Research$11,683,839
- Maurizio Del Poeta · Northport Va Medical Center$11,286,990
- Kieren A. Marr · Fred Hutchinson Cancer Research Center$10,461,474
- William J Steinbach · Duke University$8,844,552
- Borna Mehrad · University Of Florida$7,417,611
Research focus
AspergillosisInfectionAntifungal TherapyMycosesAspergillusAntifungal AgentsImmunocompromised HostMoldsMalignant NeoplasmsLungIn VivoFutureCytokineCellsPathogenImmune ResponseDoseCombatTissuesMethodologyImageInterferon Type IiMouse ModelCommunicable Diseases
Grant awards (16)
Project 3$499,545
P01 · FY2025 · AI · contact PI
Clinical Core$253,425
P01 · FY2025 · AI · contact PI
Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis$81,000
R03 · FY2023 · AI · contact PI
Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis$81,000
R03 · FY2022 · AI · contact PI
Redirected T Cell Therapy to Cure Invasive Fungal Infections$439,011
R33 · FY2021 · AI · contact PI
Redirected T Cell Therapy to Cure Invasive Fungal Infections$52,985
R33 · FY2021 · AI · contact PI
Redirected T Cell Therapy to Cure Invasive Fungal Infections$447,011
R33 · FY2020 · AI · contact PI
Redirected T Cell Therapy to Cure Invasive Fungal Infections$480,000
R33 · FY2019 · AI · contact PI
Study of the check point inhibitors with or without antifungals on the natural history of murine invasive pulmonary aspergillosis$80,000
R03 · FY2019 · AI · contact PI
Redirected T Cell Therapy to Cure Invasive Fungal Infections$225,008
R21 · FY2018 · AI · contact PI
Study of the check point inhibitors with or without antifungals on the natural history of murine invasive pulmonary aspergillosis$80,000
R03 · FY2018 · AI · contact PI
Redirected T Cell Therapy to Cure Invasive Fungal Infections$211,202
R21 · FY2017 · AI · contact PI
Novel Clinical Diagnostic Targets For Detection of Invasive Mold Aspergillosis$195,525
R21 · FY2011 · AI
Novel Clinical Diagnostic Targets For Detection of Invasive Mold Aspergillosis$237,000
R21 · FY2010 · AI
Manipulation of Host Angiogenesis as a Therapeutic Strategy against Invasive Pulm$77,000
R03 · FY2010 · AI · contact PI
Manipulation of Host Angiogenesis as a Therapeutic Strategy against Invasive Pulm$77,000
R03 · FY2009 · AI · contact PI